NCT02317848View on ClinicalTrials.gov

PRevalence, Persistence and prOgnostic ValuE of Sleep Apnea Syndrome in Acute Heart Failure

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

May 29, 2019

Study Completion Date

May 29, 2019

Conditions
Sleep Apnea SyndromeHeart Failure
Interventions
OTHER

polygraphy and ECG

polygraphy and ECG during hospitalisation for acute heart failure to see Persistence of the severity of SAS after 2 months

Trial Locations (4)

42100

Chu Saint Etienne, Saint-Etienne

75013

Chu Pitie Salpetriere, Paris

75018

Hôpital BICHAT, Paris

94010

Hôpital Henri Mondor, Créteil

All Listed Sponsors
collaborator

ResMed Foundation

OTHER

collaborator

Henri Mondor University Hospital

OTHER

lead

French Cardiology Society

OTHER

NCT02317848 - PRevalence, Persistence and prOgnostic ValuE of Sleep Apnea Syndrome in Acute Heart Failure | Biotech Hunter | Biotech Hunter